NCT02897726View on ClinicalTrials.gov

A Study to Evaluate the Safety and Pharmacokinetics of NVP-1402

PHASE1CompletedINTERVENTIONAL

Enrollment

38

Participants

Timeline

Start Date

March 24, 2017

Primary Completion Date

July 3, 2017

Study Completion Date

July 3, 2017

Conditions

Healthy

Interventions

DRUG

NVP-1402

Oral

DRUG

NVP-1402R

Oral

Trial Locations (1)

16209

Navipharm, Suwon

Sponsors

Lead Sponsor

All Listed Sponsors

lead

NVP Healthcare

INDUSTRY